Recent developments in atrial fibrillation.
作者信息
Iqbal M Bilal, Taneja Anil K, Lip Gregory Y H, Flather Marcus
机构信息
Clinical Trials and Evaluation Unit, Royal Brompton Hospital, London SW3 6NP.
出版信息
BMJ. 2005 Jan 29;330(7485):238-43. doi: 10.1136/bmj.330.7485.238.
Abstract
摘要
相似文献
1
Recent developments in atrial fibrillation.
BMJ. 2005 Jan 29;330(7485):238-43. doi: 10.1136/bmj.330.7485.238.
2
[Guidelines for the management of patients with atrial fibrillation. Executive summary].
Rev Esp Cardiol. 2006 Dec;59(12):1329.
3
Responding to atrial fibrillation.
Nursing. 2007 Apr;37(4):36-41; quiz 41-2. doi: 10.1097/01.NURSE.0000266037.44966.67.
4
Electrical and pharmacologic cardioversion for atrial fibrillation.
Cardiol Clin. 2009 Feb;27(1):95-107, ix. doi: 10.1016/j.ccl.2008.09.008.
5
An overview of atrial fibrillation.
Nurs Stand. 2012;26(52):47-56; quiz 58. doi: 10.7748/ns2012.08.26.52.47.c9254.
6
[Atrial fibrillation--treatment].
Dtsch Med Wochenschr. 2001 Dec 21;126(51-52):1472-5. doi: 10.1055/s-2001-19207.
7
The management of atrial fibrillation after cardiac surgery.
Heart. 2009 Mar;95(5):422-9. doi: 10.1136/hrt.2007.132795.
8
Atrial fibrillation: epidemiology, prognosis and therapy.
Minerva Med. 2011 Jun;102(3):187-207.
9
Cardiac arrhythmias: management of atrial fibrillation in the critically ill patient.
Crit Care Clin. 2007 Oct;23(4):855-72, vii. doi: 10.1016/j.ccc.2007.06.005.
10
Atrial fibrillation: goals of therapy and management strategies to achieve the goals.
Cardiol Clin. 2009 Feb;27(1):189-200, x. doi: 10.1016/j.ccl.2008.09.006.
引用本文的文献
1
Polyelectrolyte Microcapsules-A Promising Target Delivery System of Amiodarone with the Possibility of Prolonged Release.
Int J Mol Sci. 2023 Feb 8;24(4):3348. doi: 10.3390/ijms24043348.
2
Atrial Fibrillation's Influence on Short Sleep Duration Increases the Risk of Fatness in Management Executives.
Int J Environ Res Public Health. 2022 Apr 29;19(9):5438. doi: 10.3390/ijerph19095438.
3
Sleep Duration and Risk of Atrial Fibrillation: a Systematic Review.
J Atr Fibrillation. 2019 Apr 30;11(6):2132. doi: 10.4022/jafib.2132. eCollection 2019 Apr.
4
The Role of the Rho/ROCK Pathway in Ang II and TGF-β1-Induced Atrial Remodeling.
PLoS One. 2016 Sep 9;11(9):e0161625. doi: 10.1371/journal.pone.0161625. eCollection 2016.
5
Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studies.
Europace. 2013 Jun;15(6):787-97. doi: 10.1093/europace/eut001. Epub 2013 Feb 13.
6
Value of trans-oesophageal echocardiography as a method of encouraging patients with chronic atrial fibrillation to use anticoagulation therapy.
Cardiovasc J Afr. 2010 Jul-Aug;21(4):192-4. doi: 10.5830/cvja-2010-017.
7
Benefits and risks of long-term amiodarone therapy for persistent atrial fibrillation: a meta-analysis.
Mayo Clin Proc. 2009 Mar;84(3):234-42. doi: 10.4065/84.3.234.
8
The use of antithrombotics in patients presenting with stroke and atrial fibrillation.
Ther Clin Risk Manag. 2007 Jun;3(3):491-8.
9
[Anticoagulation for stroke prevention. An update].
Nervenarzt. 2007 Oct;78(10):1124-9. doi: 10.1007/s00115-007-2350-9.
10
Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta-analysis.
Heart. 2007 Nov;93(11):1433-40. doi: 10.1136/hrt.2006.111492. Epub 2007 Apr 20.
本文引用的文献
1
Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug.
J Am Coll Cardiol. 2003 Jul 2;42(1):20-9. doi: 10.1016/s0735-1097(03)00559-x.
2
Incidence of chronic atrial fibrillation in general practice and its treatment pattern.
J Clin Epidemiol. 2002 Apr;55(4):358-63. doi: 10.1016/s0895-4356(01)00478-4.
3
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology.
Eur Heart J. 2001 Oct;22(20):1852-923. doi: 10.1053/euhj.2001.2983.
4
Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.
JAMA. 2001 May 9;285(18):2370-5. doi: 10.1001/jama.285.18.2370.
5
Antithrombotic therapy in atrial fibrillation.
Chest. 2001 Jan;119(1 Suppl):194S-206S. doi: 10.1378/chest.119.1_suppl.194s.
6
Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm.
Am J Cardiol. 2000 Nov 1;86(9):950-3. doi: 10.1016/s0002-9149(00)01128-0.
7
Initiation of atrial fibrillation by ectopic beats originating from the superior vena cava: electrophysiological characteristics and results of radiofrequency ablation.
Circulation. 2000 Jul 4;102(1):67-74. doi: 10.1161/01.cir.102.1.67.
8
Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group.
Am J Cardiol. 1999 Aug 1;84(3):270-7. doi: 10.1016/s0002-9149(99)00275-1.
9
Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment.
N Engl J Med. 1999 Jun 17;340(24):1849-54. doi: 10.1056/NEJM199906173402401.
10
Idiopathic paroxysmal atrial fibrillation induced by a focal discharge mechanism in the left superior pulmonary vein: possible roles of the ligament of Marshall.
J Cardiovasc Electrophysiol. 1999 May;10(5):636-48. doi: 10.1111/j.1540-8167.1999.tb00240.x.
Zotero 插件